Latest debt-to-equity ratio

Clinuvel Pharmaceuticals Debt-to-equity ratio

Direct answer

Clinuvel Pharmaceuticals's debt-to-equity ratio is 0.71%.

The verified market snapshot reports 0.71%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.

Get free Clinuvel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
0.71%

Explore related company data

View Clinuvel Pharmaceuticals's market capitalizationView Clinuvel Pharmaceuticals's p/e ratioView Clinuvel Pharmaceuticals's price-to-book ratioView Clinuvel Pharmaceuticals's return on equityView Clinuvel Pharmaceuticals's dividend yieldView Clinuvel Pharmaceuticals's 52-week price rangeView Clinuvel Pharmaceuticals's revenue growthView Clinuvel Pharmaceuticals's profit marginView all Clinuvel Pharmaceuticals key metricsReturn to Clinuvel Pharmaceuticals profile